Paging Dr. GPT? Tech Investors Bet AI Finally Poised to Transform Health Care

Top venture firms are betting that rapid advances in artificial intelligence and the public fascination with ChatGPT will help tech startups to transform health care after years of Silicon Valley struggling to move the needle in the industry.

Andreessen Horowitz has been investing in a steady stream of startups that are looking to capitalize on the AI boom to improve medical care. That includes companies building AI tools to help with patient care and reduce the burden of clinical note-taking, as well as using AI to try to discover new drugs more quickly than traditional methods. Last week, the firm co-led a $200 million round in the AI-powered drug discovery company, Genesis Therapeutics. General Catalyst, Menlo Ventures, Lux Capital and others are also investing in AI health care startups.